Abstract | BACKGROUND: Recent evidence suggests that alloreactive memory T cells are generated by the process of heterologous immunity, whereby memory T cells arising in response to pathogen infection crossreact with donor antigens. Because of their diminished requirements for costimulation during recall, these pathogen-elicited allocrossreactive memory T cells are of particular clinical importance, especially given the emergence of costimulatory blockade as a transplant immunosuppression strategy. METHODS: We used an established model of heterologous immunity involving sequential infection of a naïve C57BL/6 recipient with lymphocytic choriomeningitis virus and vaccinia virus, followed by combined skin and bone marrow transplant from a BALB/c donor. RESULTS: We demonstrate that coupling the integrin antagonist anti-leukocyte functional antigen (LFA)-1 with costimulatory blockade could surmount the barrier posed by heterologous immunity in a fully allogeneic murine transplant system. The combined costimulatory and integrin blockade regimen suppressed proliferation of alloreactive memory T cells and attenuated their cytokine effector responses. This combined blockade regimen also promoted the retention of FoxP³⁺ Tregs in draining lymph nodes. Finally, we show that in an in vitro mixed lymphocyte reaction system using human T cells, the combination of belatacept and anti-LFA-1 was able to suppress cytokine production by alloreactive memory T cells that was resistant to belatacept alone. CONCLUSIONS: As an antagonist against human LFA-1 exists and has been used clinically to treat psoriasis, these findings have significant translational potential for future clinical transplant trials.
|
Authors | William H Kitchens, Divya Haridas, Maylene E Wagener, Mingqing Song, Mandy L Ford |
Journal | Transplantation
(Transplantation)
Vol. 93
Issue 10
Pg. 997-1005
(May 27 2012)
ISSN: 1534-6080 [Electronic] United States |
PMID | 22475765
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- B7 Antigens
- CD40 Antigens
- Lymphocyte Function-Associated Antigen-1
- CD40 Ligand
|
Topics |
- Animals
- B7 Antigens
(antagonists & inhibitors)
- Bone Marrow Transplantation
(immunology)
- CD40 Antigens
(antagonists & inhibitors)
- CD40 Ligand
(antagonists & inhibitors)
- Graft Rejection
(prevention & control)
- Graft Survival
- Humans
- Immunologic Memory
- Lymph Nodes
(immunology)
- Lymphocyte Activation
- Lymphocyte Function-Associated Antigen-1
(physiology)
- Male
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Skin Transplantation
(immunology)
- Transplantation, Homologous
|